1. ALLA AKTIER
  2. NYHETER
  3. PROSTATYPE GENOMICS

Prostatype Genomics

Nyheter Prostatype Genomics Nyheter alla bolag
Slipp dessa annonser och få en massa andra godsaker med vårt premiumabonnemang.

Prostatype Genomics AB: Rights issue registered and trading in paid subscription units ceases

REG

For further information about Prostatype Genomics, please contact:

Fredrik Persson, CEO

Telephone: +46 (0) 73 049 77 01.

e-mail: fredrik.persson@prostatypegenomics.com

Certified Adviser

Carnegie Investment Bank AB (publ), +46 (0)73 856 4265, certifiedadviser@carnegie.se

 

About Prostatype Genomics AB

Prostatype® is a genetic test that is available to patients and treating urologists as a supplementary decision support tool to answer the question of radical treatment or no radical treatment of prostate cancer. The test is developed by a research group at Karolinska Institutet and is provided by Prostatype Genomics AB.

 

 

 

Datum 2024-01-16, kl 09:30
Källa Cision